Christchurch Kidney Research Group, Department of Medicine, University of Otago-Christchurch, Christchurch, New Zealand.
Am J Physiol Renal Physiol. 2010 Oct;299(4):F837-44. doi: 10.1152/ajprenal.00727.2009. Epub 2010 Jul 21.
We investigated renal hemodynamics in isolated, perfused kidneys from rat models of diabetes and hypertension. Autoregulation and passive vascular responses were measured using stepped pressure ramps in the presence of angiotensin II (pEC50) or papaverine (0.1 mM), respectively. Male diabetic heterozygote m(Ren2)27 rats were compared with three male control groups: nondiabetic, normotensive Sprague-Dawley (SD) rats; nondiabetic, hypertensive heterozygote m(Ren2)27 rats; and diabetic, normotensive SD rats. Kidney function (proteinuria, creatinine clearance) was monitored before induction and at monthly intervals. Vascular function was measured in vitro in rats of induction age (6-8 wk) and at 2 and 4 mo postinduction. Renal flow correlated with age, but not diabetes or the Ren2 gene. Kidney weight-specific and body weight-specific renal flow differed between diabetic and nondiabetic rats because diabetic rats had higher kidney but lower body weights. Kidneys from all groups showed effective autoregulation in the presence of angiotensin II. The autoregulatory pressure threshold of m(Ren2)27 rats was higher, and the autoregulation pressure range was wider, compared with SD rats. When vascular smooth muscle activity was blocked with papaverine, pressure-flow responses differed between groups and with time. The m(Ren2)27 rat groups showed higher renal vascular resistance at lower pressures, suggesting greater vascular stiffness. In contrast, diabetic SD rat kidneys demonstrated reduced vessel stiffness. Flow was impaired in diabetic m(Ren2)27 rats at 4 mo, and this correlated with a decline in creatinine clearance. The results suggest that the characteristic late decline in renal filtration function in diabetes- and hypertension-related renal disease follows changes in renal vascular compliance.
我们研究了糖尿病和高血压大鼠模型的离体灌注肾脏的肾血流动力学。使用血管紧张素 II(pEC50)或罂粟碱(0.1mM)分别进行逐步压力斜坡实验来测量自动调节和被动血管反应。雄性糖尿病杂合子 m(Ren2)27 大鼠与三组雄性对照组进行比较:非糖尿病、正常血压 Sprague-Dawley(SD)大鼠;非糖尿病、高血压杂合子 m(Ren2)27 大鼠;和糖尿病、正常血压 SD 大鼠。在诱导前和每月监测一次时监测肾功能(蛋白尿、肌酐清除率)。血管功能在诱导年龄(6-8 周)的大鼠和诱导后 2 和 4 个月的大鼠中进行离体测量。肾血流量与年龄相关,但与糖尿病或 Ren2 基因无关。由于糖尿病大鼠的肾脏重量和体重比正常大鼠高,因此糖尿病和非糖尿病大鼠的肾脏重量特异性和体重特异性肾血流量不同。所有组的肾脏在血管紧张素 II 存在的情况下均表现出有效的自动调节。与 SD 大鼠相比,m(Ren2)27 大鼠的自动调节压力阈值更高,自动调节压力范围更宽。当用罂粟碱阻断血管平滑肌活性时,各组之间以及随时间的压力-流量反应不同。m(Ren2)27 大鼠组在较低的压力下表现出较高的肾血管阻力,这表明血管僵硬程度更大。相比之下,糖尿病 SD 大鼠肾脏的血管僵硬程度降低。4 个月时,糖尿病 m(Ren2)27 大鼠的血流受损,这与肌酐清除率的下降有关。结果表明,糖尿病和高血压相关肾脏疾病中晚期肾功能下降的特征是肾血管顺应性的变化。